Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
about
Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Comparison of erlotinib and pe ...... asymptomatic brain metastases
@en
type
label
Comparison of erlotinib and pe ...... asymptomatic brain metastases
@en
prefLabel
Comparison of erlotinib and pe ...... asymptomatic brain metastases
@en
P2093
P2860
P356
P1476
Comparison of erlotinib and pe ...... asymptomatic brain metastases
@en
P2093
Caicun Zhou
Christopher J Rivard
Fred R Hirsch
Shengxiang Ren
Wenwen Sun
P2860
P304
P356
10.2147/OTT.S102236
P407
P577
2016-04-21T00:00:00Z